Home > Inhibitors & Agonists > Epigenetics
Cat. No. Product name CAS No.
DC10656 (+)-JQ1 carboxylic acid

(+)-JQ1 carboxylic acid is the carboxylic acid form of (+)-JQ1 for derivative synthesis.

202592-23-2
DC5019 (+)-JQ1

(+)-JQ1 is a BET bromodomain inhibitor, binding to all bromodomains of the BET family, but not to bromodomains outside the BET family.

1268524-70-4
DC12021 (+)-JQ1 PA

(+)-JQ1 PA is a Click-activated (alkyne) version of the BET bromodomain inhibitor (+)-JQ1.

2115701-93-2
DCR-004 Ellagic acid

>98%,Standard References

476-66-4
DC10666 HDAC8 inhibitor 22d

22d is a select HDAC8 inhibitor.

1417997-93-3
DC5190 3-Deazaneplanocin A (DZNep)

3-deazaneplanocin A (DZNeP), an analog of adenosine, is a competitive inhibitor of S-adenosylhomocysteine hydrolase with Ki of 50 pM.

102052-95-9
DC10616 3-TYP

3-TYP is a selective SIRT3 inhibitor.

120241-79-4
DC8423 4SC-202 free base

4SC-202 is a selective class I HDAC inhibitor with IC50 of 1.20 μM, 1.12 μM, and 0.57 μM for HDAC1, HDAC2, and HDAC3, respectively. Also displays inhibitory activity against Lysine specific demethylase 1 (LSD1). Phase 1.

910462-43-0
DC7592 4SC-202

4SC-202 is an orally bioavailable benzamide and inhibitor of human class I histone deacetylases (HDACs) isoenzymes 1, 2 and 3, with potential antineoplastic activity. HDAC inhibitor 4SC-202 selectively binds to and inhibits class I HDACs leading to an acc

1186222-89-8
DC11652 Ischemin sodium

A cell permeable CBP bromodomain inhibitor with Kd of 19 uM.

DC11653 Ischemin

A cell permeable CBP bromodomain inhibitor with Kd of 19 uM.

1357059-00-7
DC11813 CM-414

A first-in-class, dual inhibitor of PDE5 and HDAC that inhibits HDAC1/2/3/6 (IC50=310/490/322/91 nM, respectively) and PDE5 (IC50=60 nM).

2007971-51-7
DC11815 trans CM-414

A first-in-class, dual inhibitor of PDE5 and HDAC that inhibits HDAC1/2/3/6 (IC50=310/490/322/91 nM, respectively) and PDE5 (IC50=60 nM).

1624792-73-9
DC11814 cis CM-414

A first-in-class, dual inhibitor of PDE5 and HDAC that inhibits HDAC1/2/3/6 (IC50=310/490/322/91 nM, respectively) and PDE5 (IC50=60 nM).

1624792-70-6
DC7565 BET bromodomain inhibitor,cas 1505453-59-7

A new compound which is similar with +JQ-1,BET bromodomain inhibitor

1505453-59-7
DC11793 UMB-32

A novel a potent, selective inhibitor of BRD4 with Kd of 550 nM, cellular IC50 of 724 nM.

1635437-39-6
DC11792 UMB-136

A novel bromodomain BRD4 inhibitor that significantly induces HIV-1 reactivation.

2109805-83-4
DC11880 TH1834

A novel potent specific histone acetyltransferaseTip60 inhibitor.

2108830-08-4
DC11881 TH1834 dihydrochloride

A novel potent specific histone acetyltransferaseTip60 inhibitor.

2108830-09-5
DC11696 CM-579

A novel potent, selective and reversible dual inhibitor of G9a/DNMTs with IC50 of 16 nM and 32 nM for G9a and DNMT1, respectively.

1846570-40-8
DC11585 MZ-242

A novel potent, selective Sirt2 inhibitor with IC50 of 0.118 uM.

1862238-01-4
DC11587 SirReal1

A novel potent, selective Sirt2 inhibitor with IC50 of 3.745 uM.

801227-82-7
Page 1 / Total 12 FirstPrevNextLastGoto